| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |